FDA clears Edwards Lifesciences PASCAL system for tricuspid repair
Tweet Send to a Friend
Edwards Lifesciences Corporation (NYSE: EW) announced that the U.S. Food and Drug Administration has approved its PASCAL Precision system for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




